BridgeMD
New treatment option for COVID Long-Haul
Official title Covid-19 Long Immunité IMagerie (CLIIM)
ClinicalTrials.gov ID: NCT06528171
What this study is testing
What is Specific blood samples?
Specific blood samples is an investigational medicine, being studied as a potential treatment for covid long-haul.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Covid-long pathology affects a large number of patients, and represents a major medical, economic and societal challenge. To date, we have no objective criterion for a definitive diagnosis, nor any predictive tool for monitoring the evolution of Covid-long.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- FOR CL+ PATIENTS
- Case definition in line with WHO Delphi process
You likely can't join if
- History of chronic fatigue syndrome diagnosed before or after Covid.
- History of progressive psychiatric pathology.
- History of acute Covid requiring admission to intensive care and mechanical ventilation.
- No social security affiliation. FOR CONTROL (CL-) Inclusion Criteria:
- History of acute COVID-19, mild, moderate or severe (episode at least 3 months at the time of inclusion).
- Absence of persistent symptoms more than 3 months after first Covid symptoms (or mild not affecting daily activities). Exclusion Criteria:
See the full eligibility criteria
- FOR CL+ PATIENTS
- Case definition in line with WHO Delphi process
- History of chronic fatigue syndrome diagnosed before or after Covid.
- History of progressive psychiatric pathology.
- History of acute Covid requiring admission to intensive care and mechanical ventilation.
- No social security affiliation. FOR CONTROL (CL-) Inclusion Criteria:
- History of acute COVID-19, mild, moderate or severe (episode at least 3 months at the time of inclusion).
- Absence of persistent symptoms more than 3 months after first Covid symptoms (or mild not affecting daily activities). Exclusion Criteria:
- History of progressive psychiatric pathology.
- History of acute Covid requiring admission to intensive care and mechanical ventilation.
- No social security affiliation.
- Pregnant or breast-feeding.
The study team makes the final eligibility decision.
Where it's taking place
- Nice, France
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nice, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.